+ Open data
Open data
- Basic information
Basic information
| Entry |  | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | ATR-ATRIP bound with RP-3500 | |||||||||
|  Map data | ||||||||||
|  Sample | 
 | |||||||||
|  Keywords | ATR-ATRIP inhibitor / CELL CYCLE | |||||||||
| Function / homology |  Function and homology information ATR-ATRIP complex / establishment of RNA localization to telomere / positive regulation of telomerase catalytic core complex assembly / MutSalpha complex binding / establishment of protein-containing complex localization to telomere / histone H2AXS139 kinase activity / nuclear membrane disassembly / MutLalpha complex binding / response to arsenic-containing substance / mitotic G2/M transition checkpoint ...ATR-ATRIP complex / establishment of RNA localization to telomere / positive regulation of telomerase catalytic core complex assembly / MutSalpha complex binding / establishment of protein-containing complex localization to telomere / histone H2AXS139 kinase activity / nuclear membrane disassembly / MutLalpha complex binding / response to arsenic-containing substance / mitotic G2/M transition checkpoint / regulation of double-strand break repair / nucleobase-containing compound metabolic process / positive regulation of DNA damage response, signal transduction by p53 class mediator / protein localization to chromosome, telomeric region / HDR through Single Strand Annealing (SSA) / K63-linked polyubiquitin modification-dependent protein binding / Impaired BRCA2 binding to RAD51 / negative regulation of DNA replication / replication fork processing / Presynaptic phase of homologous DNA pairing and strand exchange / site of DNA damage / replicative senescence / Regulation of HSF1-mediated heat shock response / response to mechanical stimulus / interstrand cross-link repair / Activation of ATR in response to replication stress / regulation of cellular response to heat / positive regulation of telomere maintenance via telomerase / telomere maintenance / Meiotic synapsis / DNA damage checkpoint signaling / TP53 Regulates Transcription of DNA Repair Genes / Fanconi Anemia Pathway / cellular response to gamma radiation / PML body / G2/M DNA damage checkpoint / cellular response to UV / nuclear envelope / double-strand break repair / chromosome / Processing of DNA double-strand break ends / Regulation of TP53 Activity through Phosphorylation / DNA replication / non-specific serine/threonine protein kinase / protein kinase activity / response to xenobiotic stimulus / protein serine kinase activity / DNA repair / protein serine/threonine kinase activity / DNA damage response / Golgi apparatus / DNA binding / nucleoplasm / ATP binding / nucleus Similarity search - Function | |||||||||
| Biological species |  Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.79 Å | |||||||||
|  Authors | Wang G | |||||||||
| Funding support |  China, 1 items 
 | |||||||||
|  Citation |  Journal: Sci Bull (Beijing) / Year: 2025 Title: Molecular architecture and inhibition mechanism of human ATR-ATRIP. Authors: Guangxian Wang / Po Wang / Zexuan Zheng / Qingjun Zhang / Chenchen Xu / Xinyi Xu / Lingfei Jian / Zhanpeng Zhao / Gang Cai / Xuejuan Wang /  Abstract: The ataxia telangiectasia-mutated and Rad3-related (ATR) kinase is a master regulator of DNA damage response and replication stress in humans. Targeting ATR is the focus of oncology drug pipelines ...The ataxia telangiectasia-mutated and Rad3-related (ATR) kinase is a master regulator of DNA damage response and replication stress in humans. Targeting ATR is the focus of oncology drug pipelines with a number of potent, selective ATR inhibitors currently in clinical development. Here, we determined the cryo-EM structures of the human ATR-ATRIP complex in the presence of VE-822 and RP-3500, two ATR inhibitors currently in Phase II clinical trials, achieving an overall resolution of approximately 3 Å. These structures yield a near-complete atomic model of the ATR-ATRIP complex, revealing subunit stoichiometry, intramolecular and intermolecular interactions, and critical regulatory sites including an insertion in the PIKK regulatory domain (PRD). Structural comparison provides insights into the modes of action and selectivity of ATR inhibitors. The divergent binding modes near the solvent side and in the rear pocket area of VE-822 and RP-3500, particularly their disparate binding orientations, lead to varying conformational changes in the active site. Surprisingly, one ATR-ATRIP complex binds four VE-822 molecules, with two in the ATR active site and two at the ATR-ATR dimer interface. The binding and selectivity of RP-3500 depend on two bound water molecules, which may be further enhanced by the substitution of these bound waters. Our study provides a structural framework for understanding ATR regulation and holds promise for assisting future efforts in rational drug design targeting ATR. | |||||||||
| History | 
 | 
- Structure visualization
Structure visualization
| Supplemental images | 
|---|
- Downloads & links
Downloads & links
-EMDB archive
| Map data |  emd_62811.map.gz | 204.2 MB |  EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) |  emd-62811-v30.xml  emd-62811.xml | 19.3 KB 19.3 KB | Display Display |  EMDB header | 
| Images |  emd_62811.png | 126.3 KB | ||
| Filedesc metadata |  emd-62811.cif.gz | 7.6 KB | ||
| Others |  emd_62811_half_map_1.map.gz  emd_62811_half_map_2.map.gz | 200.9 MB 200.9 MB | ||
| Archive directory |  http://ftp.pdbj.org/pub/emdb/structures/EMD-62811  ftp://ftp.pdbj.org/pub/emdb/structures/EMD-62811 | HTTPS FTP | 
-Validation report
| Summary document |  emd_62811_validation.pdf.gz | 974.2 KB | Display |  EMDB validaton report | 
|---|---|---|---|---|
| Full document |  emd_62811_full_validation.pdf.gz | 973.7 KB | Display | |
| Data in XML |  emd_62811_validation.xml.gz | 15.7 KB | Display | |
| Data in CIF |  emd_62811_validation.cif.gz | 18.8 KB | Display | |
| Arichive directory |  https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-62811  ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-62811 | HTTPS FTP | 
-Related structure data
| Related structure data |  9l4dMC  9l40C  9l43C  9l45C  9l46C  9l4bC  9l4cC  9l4fC M: atomic model generated by this map C: citing same article ( | 
|---|---|
| Similar structure data | Similarity search - Function & homology  F&H Search | 
- Links
Links
| EMDB pages |  EMDB (EBI/PDBe) /  EMDataResource | 
|---|---|
| Related items in Molecule of the Month | 
- Map
Map
| File |  Download / File: emd_62811.map.gz / Format: CCP4 / Size: 216 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
 
 Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.82 Å | ||||||||||||||||||||||||||||||||||||
| Density | 
 | ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML: 
 | 
-Supplemental data
-Half map: #2
| File | emd_62811_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices | 
 | ||||||||||||
| Density Histograms | 
-Half map: #1
| File | emd_62811_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices | 
 | ||||||||||||
| Density Histograms | 
- Sample components
Sample components
-Entire : ATR-ATRIP
| Entire | Name: ATR-ATRIP | 
|---|---|
| Components | 
 | 
-Supramolecule #1: ATR-ATRIP
| Supramolecule | Name: ATR-ATRIP / type: cell / ID: 1 / Parent: 0 / Macromolecule list: #1-#2 | 
|---|---|
| Source (natural) | Organism:  Homo sapiens (human) | 
-Macromolecule #1: Serine/threonine-protein kinase ATR
| Macromolecule | Name: Serine/threonine-protein kinase ATR / type: protein_or_peptide / ID: 1 / Number of copies: 2 / Enantiomer: LEVO / EC number: non-specific serine/threonine protein kinase | 
|---|---|
| Source (natural) | Organism:  Homo sapiens (human) | 
| Molecular weight | Theoretical: 301.001938 KDa | 
| Recombinant expression | Organism:  Homo sapiens (human) | 
| Sequence | String: LASMIPALRE LGSATPEEYN TVVQKPRQIL CQFIDRILTD VNVVAVELVK KTDSQPTSVM LLDFIQHIMK SSPLMFVNVS  GSHEAKGSC IEFSNWIITR LLRIAATPSC HLLHKKICEV ICSLLFLFKS KSPAIFGVLT KELLQLFEDL VYLHRRNVMG H AVEWPVVM  ...String: LASMIPALRE LGSATPEEYN TVVQKPRQIL CQFIDRILTD VNVVAVELVK KTDSQPTSVM LLDFIQHIMK SSPLMFVNVS  GSHEAKGSC IEFSNWIITR LLRIAATPSC HLLHKKICEV ICSLLFLFKS KSPAIFGVLT KELLQLFEDL VYLHRRNVMG H AVEWPVVM SRFLSQLDEH MGYLQSAPLQ LMSMQNLEFI EVTLLMVLTR IIAIVFFRRQ ELLLWQIGCV LLEYGSPKIK SL AISFLTE LFQLGGLPAQ PASTFFSSFL ELLKHLVEMD TDQLKLYEEP LSKLIKTLFP FEAEAYRNIE PVYLNMLLEK LCV MFEDGV LMRLKSDLLK AALCHLLQYF LKFVPAGYES ALQVRKVYVR NICKALLDVL GIEVDAEYLL GPLYAALKME SMEI IEEIQ CQTQQENLSS NSDGISPKRR RLSSSLNPSK RAPKQTEEIK HVDMNQKSIL WSALKQKAES LQISLEYSGL KNPVI EMLE GIAVVLQLTA LCTVHCSHQN MNCRTFKDCQ HKSKKKPSVV ITWMSLDFYT KVLKSCRSLL ESVQKLDLEA TIDKVV KIY DALIYMQVNS SFEDHILEDL CGMLSLPWIY SHSDDGCLKL TTFAANLLTL SCRISDSYSP QAQSRCVFLL TLFPRRI FL EWRTAVYNWA LQSSHEVIRA SCVSGFFILL QQQNSCNRVP KILIDKVKDD SDIVKKEFAS ILGQLVCTLH GMFYLTSS L TEPFSEHGHV DLFCRNLKAT SQHECSSSQL KASVCKPFLF LLKKKIPSPV KLAFIDNLHH LCKHLDFRED ETDVKAVLG  TLLNLMEDPD KDVRVAFSGN IKHILESLDS EDGFIKELFV LRMKEAYTHA QISRNNELKD TLILTTGDIG RAAKGDLVPF  ALLHLLHCL LSKSASVSGA AYTEIRALVA AKSVKLQSFF SQYKKPICQF LVESLHSSQM TALPNTPCQN ADVRKQDVAH Q REMALNTL SEIANVFDFP DLNRFLTRTL QVLLPDLAAK ASPAASALIR TLGKQLNVNR REILINNFKY IFSHLVCSCS KD ELERALH YLKNETEIEL GSLLRQDFQG LHNELLLRIG EHYQQVFNGL SILASFASSD DPYQGPRDII SPELMADYLQ PKL LGILAF FNMQLLSSSV GIEDKKMALN SLMSLMKLMG PKHVSSVRVK MMTTLRTGLR FKDDFPELCC RAWDCFVRCL DHAC LGSLL SHVIVALLPL IHIQPKETAA IFHYLIIENR DAVQDFLHEI YFLPDHPELK KIKAVLQEYR KETSESTDLQ TTLQL SMKA IQHENVDVRI HALTSLKETL YKNQEKLIKY ATDSETVEPI ISQLVTVLLK GCQDANSQAR LLCGECLGEL GAIDPG RLD FSTTETQGKD FTFVTGVEDS SFAYGLLMEL TRAYLAYADN SRAQDSAAYA IQELLSIYDC REMETNGPGH QLWRRFP EH VREILEPHLN TRYKSSQKST DWSGVKKPIY LSKLGSNFAE WSASWAGYLI TKVRHDLASK IFTCCSIMMK HDFKVTIY L LPHILVYVLL GCNQEDQQEV YAEIMAVLKH DDQHTINTQD IASDLCQLST QTVFSMLDHL TQWARHKFQA LKAEKCPHS  KSNRNKVDSM VSTVDYEDYQ SVTRFLDLIP QDTLAVASFR SKAYTRAVMH FESFITEKKQ NIQEHLGFLQ KLYAAMHEPD  GVAGVSAIR KAEPSLKEQI LEHESLGLLR DATACYDRAI QLEPDQIIHY HGVVKSMLGL GQLSTVITQV NGVHANRSEW T DELNTYRV EAAWKLSQWD LVENYLAADG KSTTWSVRLG QLLLSAKKRD ITAFYDSLKL VRAEQIVPLS AASFERGSYQ RG YEYIVRL HMLCELEHSI KPLFQHSPGD SSQEDSLNWV ARLEMTQNSY RAKEPILALR RALLSLNKRP DYNEMVGECW LQS ARVARK AGHHQTAYNA LLNAGESRLA ELYVERAKWL WSKGDVHQAL IVLQKGVELC FPENETPPEG KNMLIHGRAM LLVG RFMEE TANFESNAIM KKYKDVTACL PEWEDGHFYL AKYYDKLMPM VTDNKMEKQG DLIRYIVLHF GRSLQYGNQF IYQSM PRML TLWLDYGTKA YEWEKAGRSD RVQMRNDLGK INKVITEHTN YLAPYQFLTA FSQLISRICH SHDEVFVVLM EIIAKV FLA YPQQAMWMMT AVSKSSYPMR VNRCKEILNK AIHMKKSLEK FVGDATRLTD KLLELCNKPV DGSSSTLSMS THFKMLK KL VEEATFSEIL IPLQSVMIPT LPSILGTHAN HASHEPFPGH WAYIAGFDDM VEILASLQKP KKISLKGSDG KFYIMMCK P KDDLRKDCRL MEFNSLINKC LRKDAESRRR ELHIRTYAVI PLNDECGIIE WVNNTAGLRP ILTKLYKEKG VYMTGKELR  QCMLPKSAAL SEKLKVFREF LLPRHPPIFH EWFLRTFPDP TSWYSSRSAY CRSTAVMSMV GYILGLGDRH GENILFDSLT  GECVHVDFN CLFNKGETFE VPEIVPFRLT HNMVNGMGPM GTEGLFRRAC EVTMRLMRDQ REPLMSVLKT FLHDPLVEWS K PVKGHSKA PLNETGEVVN EKAKTHVLDI EQRLQGVIKT RNRVTGLPLS IEGHVHYLIQ EATDENLLCQ MYLGWTPYM UniProtKB: Serine/threonine-protein kinase ATR | 
-Macromolecule #2: ATR-interacting protein
| Macromolecule | Name: ATR-interacting protein / type: protein_or_peptide / ID: 2 / Number of copies: 2 / Enantiomer: LEVO | 
|---|---|
| Source (natural) | Organism:  Homo sapiens (human) | 
| Molecular weight | Theoretical: 52.802465 KDa | 
| Recombinant expression | Organism:  Homo sapiens (human) | 
| Sequence | String: WRQRSNTQGS ILINLLLKQP LIPGSSLSLC HLLSSSSESP AGTPLQPPGF GSTLAGMSGL RTTGSYDGSF SLSALREAQN  LAFTGLNLV ARNECSRDGD PAEGGRRAFP LCQLPGAVHF LPLVQFFIGL HCQALQDLAA AKRSGAPGDS PTHSSCVSSG V ETNPEDSV  ...String: WRQRSNTQGS ILINLLLKQP LIPGSSLSLC HLLSSSSESP AGTPLQPPGF GSTLAGMSGL RTTGSYDGSF SLSALREAQN  LAFTGLNLV ARNECSRDGD PAEGGRRAFP LCQLPGAVHF LPLVQFFIGL HCQALQDLAA AKRSGAPGDS PTHSSCVSSG V ETNPEDSV CILEGFSVTA LSILQHLVCH SGAVVSLLLS GVGADSAAGE GNRSLVHRLS DGDMTSALRG VADDQGQHPL LK MLLHLLA FSSAATGHLQ ASVLTQCLKV LVKLAENTSC DFLPRFQCVF QVLPKCLSPE TPLPSVLLAV ELLSLLADHD QLA PQLCSH SEGCLLLLLY MYITSRPDRV ALETQWLQLE QEVVWLLAKL GVQSPLPPVT GSNCQCNVEV VRALTVMLHR QWLT VRRAG GPPRTDQQRR TVRCLRDTVL LLHGLSQKDK LFMMHCVEVL HQFDQVMPGV SMLIRGLPDV TDCEEAALDD LCAAE TDVE DPEVECG UniProtKB: ATR-interacting protein | 
-Macromolecule #3: RP-3500
| Macromolecule | Name: RP-3500 / type: ligand / ID: 3 / Number of copies: 2 / Formula: A1EIK | 
|---|---|
| Molecular weight | Theoretical: 410.47 Da | 
-Macromolecule #4: ZINC ION
| Macromolecule | Name: ZINC ION / type: ligand / ID: 4 / Number of copies: 1 / Formula: ZN | 
|---|---|
| Molecular weight | Theoretical: 65.409 Da | 
-Experimental details
-Structure determination
| Method | cryo EM | 
|---|---|
|  Processing | single particle reconstruction | 
| Aggregation state | particle | 
- Sample preparation
Sample preparation
| Buffer | pH: 7.5 | 
|---|---|
| Vitrification | Cryogen name: ETHANE | 
- Electron microscopy
Electron microscopy
| Microscope | TFS KRIOS | 
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 50.0 e/Å2 | 
| Electron beam | Acceleration voltage: 300 kV / Electron source:  FIELD EMISSION GUN | 
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.5 µm / Nominal defocus min: 1.5 µm | 
| Experimental equipment |  Model: Titan Krios / Image courtesy: FEI Company | 
 Movie
Movie Controller
Controller

























 Z (Sec.)
Z (Sec.) Y (Row.)
Y (Row.) X (Col.)
X (Col.)




































